CP-800569
CP-800569 is an orally active cholesteryl ester transfer protein (CETP) inhibitor. CP-800569 can decrease low-density lipoprotein and postprandial triglyceride and increase high-density lipoprotein. CP-800569 can be used for the research of metabolic disease[1].
Product Specifications
CAS Number
[263262-73-3]
UNSPSC
12352005
Target
CETP
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Smiles
FC(F)C(F)(F)OC1=CC=CC(CN(C2=CC(OC3=CC(CC)=C(Cl)C=C3)=CC=C2)C[C@@H](O)C(F)(F)F)=C1
Molecular Formula
C26H23ClF7NO3
Molecular Weight
565.91
References & Citations
[1]Wolk R, et al. Pharmacokinetic, pharmacodynamic, and safety profile of a new cholesteryl ester transfer protein inhibitor in healthy human subjects. Clin Pharmacol Ther. 2009 Oct;86 (4) :430-7.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1053092-01 0.02 mg (E-Coli)
Recombinant Rhodobacter capsulatus Phosphoglycolate phosphatase (cbbZ)
Ask
View Details 
MBS1053092-02 0.1 mg (E-Coli)
Recombinant Rhodobacter capsulatus Phosphoglycolate phosphatase (cbbZ)
Ask
View Details MBS1053092-03 0.02 mg (Yeast)
Recombinant Rhodobacter capsulatus Phosphoglycolate phosphatase (cbbZ)
Ask
View Details MBS1053092-04 0.1 mg (Yeast)
Recombinant Rhodobacter capsulatus Phosphoglycolate phosphatase (cbbZ)
Ask
View Details 
MBS1053092-05 0.02 mg (Baculovirus)
Recombinant Rhodobacter capsulatus Phosphoglycolate phosphatase (cbbZ)
Ask
View Details 
MBS1053092-06 0.02 mg (Mammalian-Cell)
Recombinant Rhodobacter capsulatus Phosphoglycolate phosphatase (cbbZ)
Ask
View Details